Showing 1 - 20 results of 29 for search 'T.D. De Gruijl', query time: 0.05s
Refine Results
-
1
The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms by Luca L. G. Janssen, Luca L. G. Janssen, Nathalie van Leeuwen-Kerkhoff, Nathalie van Leeuwen-Kerkhoff, Theresia M. Westers, Theresia M. Westers, Tanja D. de Gruijl, Tanja D. de Gruijl, Tanja D. de Gruijl, Arjan A. van de Loosdrecht, Arjan A. van de Loosdrecht
Published 2024-07-01
Article -
2
-
3
Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion by Lisa A. King, Lisa A. King, Lisa A. King, Milon de Jong, Milon de Jong, Milon de Jong, Myrthe Veth, Myrthe Veth, Myrthe Veth, David Lutje Hulsik, Parsa Yousefi, Victoria Iglesias-Guimarais, Pauline M. van Helden, Tanja D. de Gruijl, Tanja D. de Gruijl, Tanja D. de Gruijl, Hans J. van der Vliet, Hans J. van der Vliet, Hans J. van der Vliet
Published 2024-10-01
Article -
4
-
5
Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring by Julie Berthe, Pawan Poudel, Felix J. Segerer, Emily C. Jennings, Felicia Ng, Michael Surace, Alma Andoni, Marco Testori, Megha Saraiya, Miljenka Vuko, Harald Hessel, Mari Heininen-Brown, Jorge Blando, Emma V. Jones, Sophie E. Willis, Jérôme Galon, Jérôme Galon, Jérôme Galon, Rieneke van de Ven, Rieneke van de Ven, Rieneke van de Ven, Tanja D. de Gruijl, Tanja D. de Gruijl, Tanja D. de Gruijl, Helen K. Angell
Published 2024-09-01
Article -
6
Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases by Sanne Samuels, Tanja D. de Gruijl, Debbie M. Ferns, A. Marijne Heeren, Maaike C. G. Bleeker, Gemma G. Kenter, Ekaterina S. Jordanova
Published 2016-12-01
Article -
7
Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation by Nathalie van Leeuwen-Kerkhoff, Theresia M. Westers, Pino J. Poddighe, Tanja D. de Gruijl, Shahram Kordasti, Arjan A. van de Loosdrecht
Published 2020-04-01
Article -
8
-
9
Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001 by Luca L.G. Janssen, Theresia M. Westers, Jeroen Rovers, Peter J.M. Valk, Jacqueline Cloos, Tanja D. de Gruijl, Arjan A. van de Loosdrecht
Published 2023-11-01
Article -
10
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic c... by Tanja D de Gruijl, Jurriaan Tuynman, Jan Spanholtz, Hans J van der Vliet, Elisa C Toffoli, Amanda A van Vliet, Henk W M Verheul
Published 2023-12-01
Article -
11
Defective Differentiation of Myeloid and Plasmacytoid Dendritic Cells in Advanced Cancer Patients is not Normalized by Tyrosine Kinase Inhibition of the Vascular Endothelial Growth... by T. D. de Gruijl, G. Giaccone, R. J. Scheper, H. van Cruijsen, K. Hoekman, B. C. Kuenen, A. J. M. van den Eertwegh, A. G. M. Stam
Published 2007-01-01
Article -
12
Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions by Tanja D de Gruijl, Roeland Lameris, Jamie Rossjohn, Myrthe Veth, David Lutje Hulsik, Adam Shahine, Bart Westerman, Dale I Godfrey, Patricia Brouwer, Hans J van der Vliet
Published 2023-12-01
Article -
13
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes by Nathalie van Leeuwen-Kerkhoff, Theresia M. Westers, Pino J. Poddighe, Giovanni A.M. Povoleri, Jessica A. Timms, Shahram Kordasti, Tanja D. de Gruijl, Arjan A. van de Loosdrecht
Published 2021-02-01
Article -
14
Absence of Granzyme B Positive Tumour-Infiltrating Lymphocytes in Primary Melanoma Excisional Biopsies is Strongly Associated with the Presence of Sentinel Lymph Node Metastasis by I. S. van Houdt, B. J. R. Sluijter, P. A. M. van Leeuwen, L. M. Moesbergen, E. Hooijberg, C. J. L. M. Meijer, T. D. de Gruijl, J. J. Oudejans, E. Boven
Published 2009-01-01
Article -
15
Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway by Tanja D de Gruijl, Rieneke van de Ven, M Petrousjka van den Tol, Kim M van Pul, Ronald J C L M Vuylsteke, Monique T A de Beijer, Hein B A C Stockmann
Published 2020-10-01
Article -
16
Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells by Joyce M. van Dodewaard-de Jong, Saskia JAM Santegoets, Peter M. van de Ven, Jurjen Versluis, Henk M. W. Verheul, Tanja D. de Gruijl, Winald R. Gerritsen, Alfons J. M. van den Eertwegh
Published 2016-04-01
Article -
17
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells by Aram M. de Haas, Dorian A. Stolk, Sjoerd T. T. Schetters, Laura Goossens-Kruijssen, Eelco Keuning, Martino Ambrosini, Louis Boon, Hakan Kalay, Gert Storm, Hans J. van der Vliet, Tanja D. de Gruijl, Yvette van Kooyk
Published 2024-04-01
Article -
18
Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer by Carolina Martinez-Ciarpaglini, Tanja D de Gruijl, Daniela S Thommen, Nicole C T van Grieken, Joep Grootjans, Sarah Derks, Tessa S Groen-van Schooten, Rosalia Franco Fernandez, Emma N Bos, Jens Seidel, Job Saris, Tania C Fleitas
Published 2024-07-01
Article -
19
Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by 18F-BMS-986192 PET: pooled analysis of data from four so... by Tanja D de Gruijl, Rieneke van de Ven, Geke A P Hospers, Marc C Huisman, Gerben J C Zwezerijnen, C Willemien Menke-van der Houven van Oordt, Iris H C Miedema, Johanna E. E. Pouw, Anne Kwakman, Florentine E F Timmer, Adrianus J de Langen
Published 2024-06-01
Article -
20
Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager by Lisa A. King, Myrthe Veth, Victoria Iglesias-Guimarais, Iris Blijdorp, Jan Kloosterman, André N. Vis, Rob C. Roovers, David Lutje Hulsik, Thilo Riedl, Anton E.P. Adang, Paul W.H.I. Parren, Pauline M. van Helden, Tanja D. de Gruijl, Hans J. van der Vliet
Published 2024-12-01
Article